HMP Market Access Insights (MAI) has been reporting on vertical payer integration since the inception of our primary payer research arm in 2022. Every year, we hear how these national players intend to further enhance their internal integration regarding business operations, policy decision making, and data sharing. However, this year we see a greater than normal ‘bump’ for what the future holds. In short, vertical payers anticipate a very high degree of integration within these critically important areas over the next few years (Figure).
Figure. Percentage of 2024 Vertical Payer Respondents Selecting “High” or “Full” Integration (N = 25).
Source: HMP Market Access Insights 2024 Payer Annual Oncology Trend Report.
We look forward to sharing additional insights later this summer when we release our full 2024 Payer Annual Trend Report, part of our suite of Oncology Customer Insights offerings!
Be sure to check out the other reports from HMP MAI:
In the interim, please feel free to reach out to Sara Stewart with any questions you may have!
In part 2 of this 3-part podcast series, HMP Executive Vice President Lee Blansett and special guest John Hennessy—health system, provider and oncology strategist—explore the operational realities of oncology practice economics.
Lee BlansettIn part 1 of this 3-part podcast series, HMP Executive Vice President Lee Blansett and special guest John Hennessy—health system, provider and oncology strategist—explore the current state of oncology practice economics.
Lee BlansettAs the Inflation Reduction Act (IRA) introduces new Maximum Fair Pricing (MFP) rules, integrated delivery networks (IDNs) and manufacturers will face the complexities of navigating overlapping 340B discounts and MFPs.
Emma Bijesse